Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Search results (18)

« Back to Publications

Favipiravir for COVID-19 in adults in the community in PRINCIPLE, an open-label, randomised, controlled, adaptive platform trial of short- and longer-term outcomes

Hobbs FR. et al, (2024), Journal of Infection, 89

Ivermectin for COVID-19 in adults in the community (PRINCIPLE): An open, randomised, controlled, adaptive platform trial of short- and longer-term outcomes

Hayward G. et al, (2024), Journal of Infection, 88

Platform adaptive trial of novel antivirals for early treatment of COVID-19 in the community (PANORAMIC): Protocol for a randomised, controlled, open-label, adaptive platform trial of community novel antiviral treatment of COVID-19 in people at increased risk of more severe disease

Gbinigie O. et al, (2023), BMJ Open, 13

Colchicine for COVID-19 in the community (PRINCIPLE): a randomised, controlled, adaptive platform trial

Dorward J. et al, (2022), British Journal of General Practice, 72, E446 - E455

Inhaled budesonide for COVID-19 in people at high risk of complications in the community in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial

Yu LM. et al, (2021), Lancet, 398, 843 - 855

Doxycycline for community treatment of suspected COVID-19 in people at high risk of adverse outcomes in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial

Butler CC. et al, (2021), The Lancet Respiratory Medicine, 9, 1010 - 1020

Inclusion and diversity in the PRINCIPLE trial

Patel MG. et al, (2021), The Lancet, 397, 2251 - 2252

zithromycin for community treatment of suspected COVID-19 in people at increased risk of an adverse clinical course in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial

Butler CC. et al, (2021), The Lancet, 397, 1063 - 1074

Colchicine for COVID-19 in adults in the community (PRINCIPLE): a randomised, controlled, adaptive platform trial

PRINCIPLE Trial Collaborative Group . et al, (2021)

Inhaled budesonide for COVID-19 in people at higher risk of adverse outcomes in the community: interim analyses from the PRINCIPLE trial

PRINCIPLE Collaborative Group . et al, (2021)

Emergency department management practices during the first year of COVID-19: A Rapid Review

Nixon MJ. et al, (2021), IMPLEMENTATION SCIENCE, 16

Determinants of Protective Behaviour Adoption and the Implications for Health Authorities During a Pandemic

Koshkouei M. and Nixon MJ., (2020), International journal of medicine and public health

The NASSS-CAT tools for understanding, guiding, monitoring, and researching technology implementation projects in health and social care: Protocol for an evaluation study in real-world settings

Greenhalgh T. et al, (2020), JMIR Research Protocols, 9

Talk Evidence covid-19 update - Remdesivir, care homes, and death data

Koshkouei M., (2020)

How can pandemic spreads be contained in care homes?

Koshkouei M. et al, (2020)

Load More